{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T09:11:06Z","timestamp":1782551466222,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,8,7]],"date-time":"2015-08-07T00:00:00Z","timestamp":1438905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,8,7]],"date-time":"2015-08-07T00:00:00Z","timestamp":1438905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1038\/cgt.2015.33","type":"journal-article","created":{"date-parts":[[2015,8,7]],"date-time":"2015-08-07T10:21:05Z","timestamp":1438942865000},"page":"445-453","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Expression of p53 synergistically augments caspases-mediated apoptosis induced by replication-competent adenoviruses in pancreatic carcinoma cells"],"prefix":"10.1038","volume":"22","author":[{"given":"Y","family":"Takei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Morinaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Shingyoji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Sekine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Tada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Tatsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1990-8217","authenticated-orcid":false,"given":"H","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Hiroshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Tagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,7]]},"reference":[{"key":"BFcgt201533_CR1","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","volume":"57","author":"A Jemal","year":"2007","unstructured":"Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ . Cancer statistics. CA Cancer J Clin 2007; 57: 43\u201366.","journal-title":"CA Cancer J Clin"},{"key":"BFcgt201533_CR2","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00280-013-2368-6","volume":"73","author":"K Sudo","year":"2014","unstructured":"Sudo K, Ishihara T, Hirata N, Ozawa F, Ohshima T, Azemoto R et al. Randomized controlled study of gemcitabine plus S-1 combination chemotherapy versus gemcitabine for unresectable pancreatic cancer. Cancer Chemother Pharmacol 2014; 73: 389\u2013396.","journal-title":"Cancer Chemother Pharmacol"},{"key":"BFcgt201533_CR3","first-page":"3273","volume":"23","author":"M Tomizawa","year":"2003","unstructured":"Tomizawa M, Saisho H, Tagawa M . Regulatory regions of growth-related genes can activate an exogenous gene of the \u03b1-fetoprotein promoter to a comparable degree in human hepatocellular carcinoma cells. Anticancer Res 2003; 23: 3273\u20133277.","journal-title":"Anticancer Res"},{"key":"BFcgt201533_CR4","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1349-7006.1999.tb00771.x","volume":"90","author":"M Miyauchi","year":"1999","unstructured":"Miyauchi M, Shimada H, Kadomatsu K, Muramatsu T, Matsubara S, Ikematsu S et al. Frequent expression of midkine gene in esophageal cancer suggests a potential usage of its promoter for suicide gene therapy. Jpn J Cancer Res 1999; 90: 469\u2013475.","journal-title":"Jpn J Cancer Res"},{"key":"BFcgt201533_CR5","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1016\/j.ejca.2004.04.014","volume":"40","author":"L Yu","year":"2004","unstructured":"Yu L, Hamada K, Namba M, Kadomatsu K, Muramatsu T, Matsubara S et al. Midkine promoter-driven suicide gene expression and -mediated adenovirus replication produced cytotoxic effects to immortalized and tumour cells. Eur J Cancer 2004; 40: 1787\u20131794.","journal-title":"Eur J Cancer"},{"key":"BFcgt201533_CR6","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1128\/JVI.74.6.2567-2583.2000","volume":"74","author":"DM Shayakhmetov","year":"2000","unstructured":"Shayakhmetov DM, Papayannopoulou T, Stamatoyannopoulos G, Lieber A . Efficient gene transfer into human CD34+ cells by a retargeted adenovirus vector. J Virol 2000; 74: 2567\u20132583.","journal-title":"J Virol"},{"key":"BFcgt201533_CR7","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1038\/nm952","volume":"9","author":"A Gaggar","year":"2003","unstructured":"Gaggar A, Shayakhmetov DM, Lieber A . CD46 is a cellular receptor for group B adenoviruses. Nat Med 2003; 9: 1408\u20131412.","journal-title":"Nat Med"},{"key":"BFcgt201533_CR8","first-page":"831","volume":"14","author":"L Yu","year":"2005","unstructured":"Yu L, Takenobu H, Shimozato O, Kawamura K, Nimura Y, Seki N et al. Increased infectivity of adenovirus type 5 bearing type 11 or type 35 fibers to human esophageal and oral carcinoma cells. Oncol Rep 2005; 14: 831\u2013835.","journal-title":"Oncol Rep"},{"key":"BFcgt201533_CR9","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1111\/cas.12267","volume":"104","author":"M Takagi-Kimura","year":"2013","unstructured":"Takagi-Kimura M, Yamano T, Tamamoto A, Okamura N, Okamura H, Hashimoto-Tamaoki T et al. Enhanced antitumor efficacy of fiber-modified, midkine promoter-regulated oncolytic adenovirus in human malignant mesothelioma. Cancer Sci 2013; 104: 1433\u20131439.","journal-title":"Cancer Sci"},{"key":"BFcgt201533_CR10","first-page":"2311","volume":"27","author":"L Yu","year":"2007","unstructured":"Yu L, Shimozato O, Li Q, Kawamura K, Ma G, Namba M et al. Adenovirus type 5 substituted with type 11 or type 35 fiber structure increases its infectivity to human cells and enables dual gene transfer in CD46-dependent and -independent manners. Anticancer Res 2007; 27: 2311\u20132316.","journal-title":"Anticancer Res"},{"key":"BFcgt201533_CR11","first-page":"2140","volume":"5","author":"M Kusumoto","year":"1999","unstructured":"Kusumoto M, Ogawa T, Mizumoto K, Ueno H, Niiyama H, Sato N et al. Adenovirus-mediated p53 gene transduction inhibits telomerase activity independent of its effects on cell cycle arrest and apoptosis in human pancreatic cancer cells. Clin Cancer Res 1999; 5: 2140\u20132147.","journal-title":"Clin Cancer Res"},{"key":"BFcgt201533_CR12","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1112>3.0.CO;2-X","volume":"91","author":"M Miyauchi","year":"2001","unstructured":"Miyauchi M, Yoshida Y, Tada Y, Narita M, Maeda T, Bahar R et al. Expression of herpes simplex virus-thymidine kinase gene controlled by a promoter region of the midkine gene confers selective cytotoxicity to ganciclovir in human carcinoma cells. Int J Cancer 2001; 91: 723\u2013727.","journal-title":"Int J Cancer"},{"key":"BFcgt201533_CR13","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1089\/104303401750270995","volume":"12","author":"J Mi","year":"2001","unstructured":"Mi J, Li ZY, Ni S, Steinwaerder D, Lieber A . Induced apoptosis supports spread of adenovirus vectors in tumors. Hum Gene Ther 2001; 12: 1343\u20131352.","journal-title":"Hum Gene Ther"},{"key":"BFcgt201533_CR14","first-page":"6165","volume":"62","author":"VW van Beusechem","year":"2002","unstructured":"van Beusechem VW, van den Doel PB, Grill J, Pinedo HM, Gerritsen WR . Conditionally replicative adenovirus expressing p53 exhibits enhanced oncolytic potency. Cancer Res 2002; 62: 6165\u20136171.","journal-title":"Cancer Res"},{"key":"BFcgt201533_CR15","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1016\/j.ejca.2011.12.020","volume":"48","author":"Y Yamasaki","year":"2012","unstructured":"Yamasaki Y, Tazawa H, Hashimoto Y, Kojima T, Kuroda S, Yano S et al. A novel apoptotic mechanism of genetically engineered adenovirus-mediated tumour-specific p53overexpression through E1A-dependent p21 and MDM2 suppression. Eur J Cancer 2012; 48: 2282\u20132291.","journal-title":"Eur J Cancer"},{"key":"BFcgt201533_CR16","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1158\/1535-7163.MCT-12-0869","volume":"12","author":"J Hasei","year":"2013","unstructured":"Hasei J, Sasaki T, Tazawa H, Osaki S, Yamakawa Y, Kunisada T et al. Dual programmed cell death pathways induced by p53 transactivation overcome resistance to oncolytic adenovirus in human osteosarcoma cells. Mol Cancer Ther 2013; 12: 314\u2013325.","journal-title":"Mol Cancer Ther"},{"key":"BFcgt201533_CR17","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/cgt.2011.86","volume":"19","author":"Q Li","year":"2012","unstructured":"Li Q, Kawamura K, Okamoto S, Yamanaka M, Yang S, Yamauchi S et al. Upregulated p53 expression activates apoptotic pathways in wild-type p53-bearing mesothelioma and enhances cytotoxicity of cisplatin and pemetrexed. Cancer Gene Ther 2012; 19: 218\u2013228.","journal-title":"Cancer Gene Ther"},{"key":"BFcgt201533_CR18","first-page":"2737","volume":"63","author":"F R\u00f6dicker","year":"2003","unstructured":"R\u00f6dicker F, P\u00fctzer BM . p73 is effective in p53-null pancreatic cancer cells resistant to wild-type TP53 gene replacement. Cancer Res 2003; 63: 2737\u20132741.","journal-title":"Cancer Res"},{"key":"BFcgt201533_CR19","first-page":"639","volume":"1","author":"AL Gartel","year":"2002","unstructured":"Gartel AL, Tyner AL . The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther 2002; 1: 639\u2013649.","journal-title":"Mol Cancer Ther"},{"key":"BFcgt201533_CR20","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/cgt.2009.29","volume":"16","author":"M Shiina","year":"2009","unstructured":"Shiina M, Lacher MD, Christian C, Korn WM . RNA interference-mediated knockdown of p21(WAF1) enhances anti-tumor cell activity of oncolytic adenoviruses. Cancer Gene Ther 2009; 16: 810\u2013819.","journal-title":"Cancer Gene Ther"},{"key":"BFcgt201533_CR21","first-page":"1163","volume":"15","author":"P Martin-Duque","year":"1999","unstructured":"Martin-Duque P, S\u00e1nchez-Prieto R, Romero J, Martinez-Lamparero A, Cebrian-Sagarriga S, Guinea-Viniegra J et al. In vivo radiosensitizing effect of the adenovirus E1A gene in murine and human malignant tumors. Int J Oncol 1999; 15: 1163\u20131168.","journal-title":"Int J Oncol"},{"key":"BFcgt201533_CR22","first-page":"6229","volume":"63","author":"WP Lee","year":"2003","unstructured":"Lee WP, Tai DI, Tsai SL, Yeh CT, Chao Y, Lee SD et al. Adenovirus type 5 E1A sensitizes hepatocellular carcinoma cells to gemcitabine. Cancer Res 2003; 63: 6229\u20136236.","journal-title":"Cancer Res"},{"key":"BFcgt201533_CR23","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.cell.2009.04.037","volume":"137","author":"KH Vousden","year":"2009","unstructured":"Vousden KH, Prives C . Blinded by the light: the growing complexity of p53. Cell 2009; 137: 413\u2013431.","journal-title":"Cell"},{"key":"BFcgt201533_CR24","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1074\/jbc.M611043200","volume":"283","author":"K Fujiwara","year":"2008","unstructured":"Fujiwara K, Daido S, Yamamoto A, Kobayashi R, Yokoyama T, Aoki H et al. Pivotal role of the cyclin-dependent kinase inhibitor p21WAF1\/CIP1 in apoptosis and autophagy. J Biol Chem 2008; 283: 388\u2013397.","journal-title":"J Biol Chem"},{"key":"BFcgt201533_CR25","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1089\/104303402760372954","volume":"13","author":"H Sauthoff","year":"2002","unstructured":"Sauthoff H, Pipiya T, Heitner S, Chen S, Norman RG, Rom WN et al. Late expression of p53 from a replicating adenovirus improves tumor cell killing and is more tumor cell specific than expression of the adenoviral death protein. Hum Gene Ther 2002; 13: 1859\u20131871.","journal-title":"Hum Gene Ther"},{"key":"BFcgt201533_CR26","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.4161\/cc.5.19.3263","volume":"5","author":"G Cherubini","year":"2006","unstructured":"Cherubini G, Petouchoff T, Grossi M, Piersanti S, Cundari E, Saggio I . E1B55K-deleted adenovirus (ONYX-015) overrides G1\/S and G2\/M checkpoints and causes mitotic catastrophe and endoreduplication in p53-proficient normal cells. Cell Cycle 2006; 5: 2244\u20132252.","journal-title":"Cell Cycle"},{"key":"BFcgt201533_CR27","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1158\/1535-7163.MCT-06-0631","volume":"6","author":"HC Graat","year":"2007","unstructured":"Graat HC, Carette JE, Schagen FH, Vassilev LT, Gerritsen WR, Kaspers GJ et al. Enhanced tumor cell kill by combined treatment with a small-molecule antagonist of mouse double minute 2 and adenoviruses encoding p53. Mol Cancer Ther 2007; 6: 1552\u20131561.","journal-title":"Mol Cancer Ther"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cgt201533.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt201533","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt201533.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T12:31:34Z","timestamp":1647952294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cgt201533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,7]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["BFcgt201533"],"URL":"https:\/\/doi.org\/10.1038\/cgt.2015.33","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,7]]},"assertion":[{"value":"21 November 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}